Georgia Wells / Wall Street Journal ·
A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup that raised $36M to design antibody drugs against pathogens, including AI-enabled bioweapons
Red Queen Bio is using artificial intelligence to design antibody drugs for novel pathogens